Total Payments
$2,842
2024 Payments
$669.63
Companies
14
Transactions
62
Medicare Patients
336
Medicare Billing
$76,462
Payment Breakdown by Category
Food & Beverage$2,713 (95.5%)
Education$129.08 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,713 | 58 | 95.5% |
| Education | $129.08 | 4 | 4.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $768.35 | 10 | $0 (2023) |
| Novo Nordisk Inc | $668.63 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $363.12 | 6 | $0 (2024) |
| ABBVIE INC. | $290.61 | 10 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $163.09 | 4 | $0 (2024) |
| Lilly USA, LLC | $108.01 | 7 | $0 (2023) |
| ViiV Healthcare Company | $96.60 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $96.16 | 1 | $0 (2024) |
| Esperion Therapeutics, Inc. | $95.64 | 1 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.29 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $669.63 | 14 | ABBVIE INC. ($205.84) |
| 2023 | $720.10 | 15 | AstraZeneca Pharmaceuticals LP ($232.04) |
| 2022 | $620.05 | 13 | Novo Nordisk Inc ($275.14) |
| 2021 | $831.82 | 20 | Janssen Pharmaceuticals, Inc ($437.58) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Respiratory | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $95.83 | General |
| Category: Obesity | ||||||
| 06/12/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $96.60 | General |
| 06/06/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Durable Pump | ||||||
| 04/30/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $96.16 | General |
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Cardio-renal | ||||||
| 04/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: NEUROSCIENCE | ||||||
| 03/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Obesity | ||||||
| 02/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $101.20 | General |
| Category: Respiratory | ||||||
| 11/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: Obesity | ||||||
| 10/25/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $120.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $103.31 | General |
| Category: Neuroscience | ||||||
| 09/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Obesity | ||||||
| 08/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Cardio-renal | ||||||
| 06/13/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $105.97 | General |
| Category: Neuroscience | ||||||
| 03/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $101.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2023 | Abbott Laboratories | ID NOW INSTRUMENT (Device) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: Rapid Diagnostics | ||||||
| 02/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $120.84 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 116 | 897 | $99,060 | $31,688 |
| 2022 | 4 | 59 | 258 | $41,203 | $14,502 |
| 2021 | 5 | 93 | 176 | $54,009 | $14,816 |
| 2020 | 4 | 68 | 237 | $62,212 | $15,456 |
Total Patients
336
Total Services
1,568
Medicare Billing
$76,462
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 147 | $25,755 | $11,860 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 137 | $20,550 | $7,913 | 38.5% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 15 | 117 | $14,040 | $3,627 | 25.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 15 | 112 | $16,800 | $3,542 | 21.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 275 | $16,515 | $2,450 | 14.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 65 | $3,250 | $1,398 | 43.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 19 | $1,900 | $688.12 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 25 | $250.00 | $210.00 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 23 | 118 | $21,113 | $9,102 | 43.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2022 | 12 | 67 | $8,040 | $2,291 | 28.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 13 | 62 | $9,300 | $1,905 | 20.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 11 | 11 | $2,750 | $1,204 | 43.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 61 | $27,696 | $7,350 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 62 | $18,924 | $4,805 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 13 | 13 | $4,285 | $1,457 | 34.0% |
| 0031A | Adm sarscov2 vac ad26 .5ml | Office | 2021 | 25 | 25 | $2,430 | $972.00 | 40.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 15 | 15 | $675.00 | $232.65 | 34.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 29 | 130 | $35,016 | $8,409 | 24.0% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 17 | 56 | $18,527 | $4,865 | 26.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 20 | $7,320 | $1,886 | 25.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 31 | $1,349 | $296.51 | 22.0% |
About Moline Blanc
Moline Blanc is a Physician Assistant healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2015. The National Provider Identifier (NPI) number assigned to this provider is 1215306998.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Moline Blanc has received a total of $2,842 in payments from pharmaceutical and medical device companies, with $669.63 received in 2024. These payments were reported across 62 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,713).
As a Medicare-enrolled provider, Blanc has provided services to 336 Medicare beneficiaries, totaling 1,568 services with total Medicare billing of $76,462. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Orange City, FL
- Active Since 09/23/2015
- Last Updated 04/07/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215306998
Products in Payments
- XARELTO (Drug) $453.64
- Wegovy (Drug) $393.49
- SPRAVATO (Drug) $314.71
- FARXIGA (Drug) $232.04
- VRAYLAR (Drug) $208.91
- Kerendia (Drug) $163.09
- Rybelsus (Drug) $131.75
- AIRSUPRA (Drug) $115.92
- NEXLIZET (Drug) $95.64
- Ozempic (Drug) $75.08
- JARDIANCE (Drug) $72.20
- Saxenda (Drug) $68.31
- UBRELVY (Drug) $51.38
- CONTRAVE (Drug) $47.83
- ID NOW INSTRUMENT (Device) $43.44
- EMGALITY (Drug) $41.46
- TRULICITY (Drug) $34.66
- QULIPTA (Drug) $30.32
- SOLIQUA 100/33 (Biological) $22.78
- MINIMED 780G (Device) $20.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Orange City
Atlanta Cranias, Pa-C, PA-C
Physician Assistant — Payments: $9,102
Physician Assistant $9,102
Payne Drewelow
Physician Assistant — Payments: $6,226
Physician Assistant $6,226
Laurie Letizia, Pa-C, PA-C
Physician Assistant — Payments: $4,893
Physician Assistant $4,893
Ms. Kristyn Wong
Physician Assistant — Payments: $4,704
Physician Assistant $4,704
Emily Robinson, Pa-C, PA-C
Physician Assistant — Payments: $3,106
Physician Assistant $3,106
Cynthia Luciano, Pa-C, PA-C
Physician Assistant — Payments: $2,735
Physician Assistant $2,735